Czirr James C's Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Dec 18, 2025
- Accession no.
- 0001493152-25-028303
- Filed
- Dec 18, 2025, 10:34 AM ET
- Trade date
- Nov 24-Dec 16, 2025
- Filing delay
- 24 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $204.3K. It was filed 24 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Czirr James CCIK 0001260641 | 10% Owner |
| 10X Fund, L.P.CIK 0001453356 | 10% Owner |
| 10X Capital Management, LLCCIK 0001457247 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | JOtherDisposed | −24,000 | – | – | 5,645,138 | Direct | |
| Dec 16, 2025 | Common Stock | SSaleDisposed | −30,681 | $6.66 | −$204,335.46 | 5,614,457 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.